• Tuesday, Jul 07, 2020
  • Last Update : 09:14 am

Chinese company, university and GSK to jointly develop coronavirus vaccine

  • Published at 08:17 pm April 9th, 2020
Vaccine
Bigstock

'In combination with adjuvant system AS03, the recombinant protein-based vaccine candidate is expected to induce a high level of protective immunity to meet the urgent need for Covid-19 prevention'

Xiamen Innovax Biotech Co. Ltd., a subsidiary of China's Yangshengtang Group in eastern China's Zhejiang Province, and Xiamen University have announced cooperation with British pharmaceutical giant GlaxoSmithKline (GSK), to do an evaluation for a recombinant protein-based vaccine candidate for Covid-19.

Gao Yongzhong, general manager of Xiamen Innovax, said that GSK will give an adjuvant framework that will be utilized in pre-clinical preliminaries for a vaccine candidate created by their organization and Xiamen University, UNB reports quoting Xinhua.

He added, "In combination with adjuvant system AS03, the recombinant protein-based vaccine candidate is expected to induce a high level of protective immunity to meet the urgent need for Covid-19 prevention,"

Thomas Breuer, GSK Vaccines chief medical officer, said that as one of their technological advantages, the adjuvant they produced can help enhance the body's immune response when it is added to the vaccine and an ideal combination is able to develop stronger and more durable immunity than a single vaccine.

"The use of adjuvant amid the Covid-19 pandemic is very important because it helps to produce more doses of vaccine and allows more people to be vaccinated," said Breuer.

According to GSK, the adjuvant can expand the immunogenicity, reaction speed and resistance of antigens and in the interim lessen their utilization. At the point when a similar portion of vaccine antigen meets a perfect adjuvant, it can deliver more vaccines with a similar impact simultaneously, which is useful to large scale manufacturing of vaccines for the pandemic.

At the moment, the cooperation between the three parties incorporates pre-clinical preliminaries in the first period and if it is detected to show good prospects, they will at that point start clinical preliminaries.

99
95
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail